CAGNACCI, ANGELO
 Distribuzione geografica
Continente #
EU - Europa 15.168
AS - Asia 2.453
NA - Nord America 2.348
Continente sconosciuto - Info sul continente non disponibili 581
SA - Sud America 162
AF - Africa 38
OC - Oceania 5
Totale 20.755
Nazione #
IT - Italia 14.630
US - Stati Uniti d'America 2.214
SG - Singapore 870
CN - Cina 635
VN - Vietnam 386
BD - Bangladesh 340
FR - Francia 190
CH - Svizzera 138
BR - Brasile 95
FI - Finlandia 86
HK - Hong Kong 79
CA - Canada 50
DE - Germania 33
AR - Argentina 29
IN - India 28
JM - Giamaica 22
MX - Messico 21
GB - Regno Unito 17
ID - Indonesia 16
EC - Ecuador 14
NL - Olanda 12
TH - Thailandia 12
ZA - Sudafrica 12
IQ - Iraq 11
JP - Giappone 10
CO - Colombia 9
UZ - Uzbekistan 9
KR - Corea 8
PH - Filippine 8
AT - Austria 7
BB - Barbados 7
BE - Belgio 7
PL - Polonia 7
CL - Cile 6
CR - Costa Rica 6
PK - Pakistan 6
SV - El Salvador 6
UA - Ucraina 6
DZ - Algeria 5
MA - Marocco 5
MY - Malesia 5
PY - Paraguay 5
TR - Turchia 5
DK - Danimarca 4
ES - Italia 4
HN - Honduras 4
PT - Portogallo 4
TT - Trinidad e Tobago 4
AU - Australia 3
CZ - Repubblica Ceca 3
GT - Guatemala 3
IE - Irlanda 3
JO - Giordania 3
KE - Kenya 3
NI - Nicaragua 3
NP - Nepal 3
RU - Federazione Russa 3
TW - Taiwan 3
CW - ???statistics.table.value.countryCode.CW??? 2
KG - Kirghizistan 2
LB - Libano 2
LC - Santa Lucia 2
MD - Moldavia 2
NG - Nigeria 2
SC - Seychelles 2
SE - Svezia 2
SI - Slovenia 2
TJ - Tagikistan 2
TN - Tunisia 2
VE - Venezuela 2
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
DJ - Gibuti 1
EG - Egitto 1
ET - Etiopia 1
FJ - Figi 1
GP - Guadalupe 1
HR - Croazia 1
IM - Isola di Man 1
IR - Iran 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
Totale 20.171
Città #
Genova 8.034
Genoa 4.074
Vado Ligure 1.267
Rapallo 834
San Jose 451
Singapore 357
Ashburn 288
Lauterbourg 181
Zurich 136
New York 110
Ho Chi Minh City 104
Hanoi 94
Bordighera 84
Helsinki 83
Beijing 78
Council Bluffs 77
Hong Kong 75
Santa Clara 73
Los Angeles 53
Milan 52
St Louis 42
Dallas 36
Buffalo 31
Rome 28
Frankfurt am Main 19
Boardman 18
Bologna 17
Houston 17
Chicago 15
Da Nang 14
Haiphong 14
Naples 14
Turin 14
Kingston 13
Mexico City 13
Brooklyn 11
Atlanta 10
Philadelphia 10
Denver 9
Jacksonville 9
Las Vegas 9
Tashkent 9
Miami 8
Mumbai 8
Palermo 8
Queens 8
Quito 8
San Francisco 8
São Paulo 8
Tokyo 8
Austin 7
Boston 7
Brussels 7
Figino 7
Jakarta 7
Phoenix 7
San Antonio 7
Washington 7
Biên Hòa 6
Bridgetown 6
Can Tho 6
Columbus 6
Detroit 6
El Paso 6
Lyndhurst 6
Orem 6
Toronto 6
Bangkok 5
Cleveland 5
Hays 5
London 5
Montreal 5
Newark 5
Oakland 5
Oklahoma City 5
Portland 5
Richmond 5
San José 5
Seregno 5
The Bronx 5
Tianjin 5
Arlington 4
Augusta 4
Bellingham 4
Brasília 4
Campinas 4
Cape Town 4
Charlotte 4
Da Lat 4
Federal Way 4
Florence 4
Guangzhou 4
Johannesburg 4
Kuala Lumpur 4
Louisville 4
Marietta 4
Memphis 4
Ninh Bình 4
Orlando 4
Pasadena 4
Totale 17.197
Nome #
Relation between blood pressure and genito-urinary symptoms in the years across the menopausal age 265
Vasomotor symptoms in menopause: a biomarker of cardiovascular disease risk and other chronic diseases? 182
Asymptomatic SARS-CoV-2 infections in pregnant patients in an Italian city during the complete lockdown 173
Modification of body composition and metabolism during oral contraceptives containing non-androgenic progestins in association with estradiol or ethinyl estradiol 157
Acupuncture or phy(F)itoestrogens vs. (E)strogen plus progestin on menopausal symptoms. A randomized study 154
Maternal age and the risk of adverse pregnancy outcomes: a retrospective cohort study 151
Age at Menopause and Extent of Coronary Artery Disease Among Postmenopausal Women with Acute Coronary Syndromes 148
Adenomyosis of the Extrapelvic Portion of the Round Ligament 144
Age at menopause, extent of coronary artery disease and outcome among postmenopausal women with acute coronary syndromes 144
Association between urinary incontinence and climacteric symptoms in postmenopausal women 142
Progestin suppressed inflammation and cell viability of tumor necrosis factor-α-stimulated endometriotic stromal cells 142
Administration of raloxifene does not influence 24-hour ambulatory blood pressure of postmenopausal women with osteopenia: a double-blind placebo-controlled study 141
Attitudes and perceptions towards vulvar and vaginal atrophy in Italian post-menopausal women: Evidence from the European REVIVE survey 141
Angle of Uterine Flexion and Adenomyosis 140
Administration of tibolone decreases 24h heart rate but not blood pressure of post-menopausal women 140
Dienogest mediates midkine suppression in endometriosis 135
The Association between Endometriomas and Ovarian Cancer: Preventive Effect of Inhibiting Ovulation and Menstruation during Reproductive Life 133
Are climacteric complaints associated with risk factors of cardiovascular disease in peri-menopausal women? 132
Venous thrombosis and hormonal contraception: what's new with estradiol-based hormonal contraceptives? 130
Association between pelvic organ prolapse and climacteric symptoms in postmenopausal women 130
A comparison of the central effects of different progestins used in hormone replacement therapy 129
Integrated Clinical Pathways in vaginal and caesarean delivery: effect analysis 2016-2017, Italy 128
The Controversial History of Hormone Replacement Therapy 127
Vasomotor symptoms and management of women undergoing treatment for breast cancer: literature review with focus on the therapeutic potential of cytoplasmic pollen extract 126
Route of administration of contraceptives containing desogestrel/etonorgestrel and insulin sensitivity: a prospective randomized study 125
Prospective measurement of blood pressure and heart rate over 24 h in women using combined oral contraceptives with estradiol 125
Effect of COVID-19 Vaccine in Women with Adenomyosis and Endometriosis 125
Bleeding profile in users of an etonogestrel sub-dermal implant: Effects of anthropometric variables. An observational uncontrolled preliminary study in Italian population 124
Does dienogest influence the inflammatory response of endometriotic cells? A systematic review 123
Hereditary Ovarian Cancer: Not Only BRCA 1 and 2 Genes 123
Relation between adenomyosis and elastographic characteristics of the cervix 122
Anthropometric Features and Third-Fourth Degree Perineal Tears 122
Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial 122
Oral contraceptives and insulin sensitivity 120
Diagnosis and management of symptoms associated with vulvovaginal atrophy: expert opinion on behalf of the Italian VVA study group (.) 119
Recommendations for contraception in women with diabetes. AMD-SIC position paper 119
Increased cortisol level: a possible link between climacteric symptoms and cardiovascular risk factors 119
Impact of vulvovaginal atrophy of menopause: prevalence and symptoms in Italian women according to the EVES study 118
Occurrence of smooth endoplasmic reticulum aggregates in metaphase II oocytes: relationship with stimulation protocols and outcome of ICSI and IVF cycles 118
Gut Microbiota and Endometriosis: Exploring the Relationship and Therapeutic Implications 116
Body composition and resting metabolic rate of perimenopausal women using continuous progestogen contraception 116
Prediction of age at menopause from assessment of ovarian reserve may be improved by using body mass index and smoking status 116
Intermenstrual pelvic pain, quality of life and mood 115
Hormone replacement therapy and prevention of chronic conditions 115
The most bothersome symptom of vaginal atrophy: Evidence from the observational AGATA study 115
Seasonal trend of acute pelvic inflammatory disease 114
Monurelle Biogel® vaginal gel in the treatment of vaginal dryness in postmenopausal women 114
Cyclic progestin administration increases energy expenditure and decreases body fat mass in perimenopausal women 112
The Benefit of Transvaginal Elastography in Detecting Deep Endometriosis: A Feasibility Study 111
Gynaecological pathologies leading to emergency department admissions: A cross-sectional study 111
Comparison of the effect of oral and transdermal hormone therapy on fasting and postmethionine homocysteine levels 111
Counseling on vaginal delivery of contraceptive hormones: implications for women's body knowledge and sexual health 111
“In patient” medical abortion versus surgical abortion: patient’s satisfaction 111
ISPOG European Consensus Statement - chronic pelvic pain in women (short version) 110
Modification of blood pressure in postmenopausal women: role of hormone replacement therapy 110
Vaginal atrophy across the menopausal age: results from the ANGEL study 110
Role of a natural integrator based on lipoic acid, palmitoiletanolamide and myrrh in the treatment of chronic pelvic pain and endometriosis 110
Impact of laparoscopic cystectomy of endometriotic and non-endometriotic cysts on ovarian volume, antral follicle count (AFC) and ovarian doppler velocimetry 109
Pharmacokinetic evaluation of desogestrel as a female contraceptive 109
The relation of season of birth to severity of menopausal symptoms 109
Kava-Kava administration reduces anxiety in perimenopausal women 109
Relation of homocysteine, folate, and vitamin B12 to bone mineral density of postmenopausal women 108
Menstrual Pain and Elasticity of Uterine Cervix 108
Medical and patient attitude towards vaginal atrophy: the AGATA study 107
Treatment continuation and satisfaction in women using combined oral contraception with nomegestrol acetate and oestradiol: a multicentre, prospective cohort study (BOLERO) 107
Relation between oxidative stress and climacteric symptoms in early postmenopausal women 105
Clinical effect of hormonal replacement therapy with estradiol associated with noretisterone or drospirenone. A prospective randomized placebo controlled study 105
Massive Hemoperitoneum from Uterine Leiomyoma Associated with Diffuse Myometrial Venous Congestion 105
High-dose short-term folate administration modifies ambulatory blood pressure in postmenopausal women. A placebo-controlled study 104
Management of vaginal atrophy: a real mess. Results from the AGATA study 104
Vaginal atrophy of women in postmenopause. Results from amulticentric observational study: The AGATA study 104
Seasonal onset of the menopause 104
The ovarian response to controlled stimulation in IVF cycles may be predictive of the age at menopause 104
Influences of maternal weight on the secondary sex ratio of human offspring 103
European society of contraception statement on contraception in obese women 103
Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family History 103
Sexual dimorphism in the levels of amniotic fluid leptin in pregnancies at 16 weeks of gestation 102
Menopausal symptoms and risk factors for cardiovascular disease in postmenopause 102
Intensity of menstrual pain and estimated angle of uterine flexion 101
Role of close endocervical margin in treatment failure after cervical excision for cervical intraepithelial neoplasia: A retrospective study 101
Levonorgestrel administration in emergency contraception: bleeding pattern and pituitary-ovarian function 100
Raloxifene does not influence flow-mediated endothelium-dependent and endothelium-independent vasodilatation of osteopenic postmenopausal women 100
Relationship between urinary estrogen levels before conception and sex ratio at birth in a primate, the gray mouse lemur 100
Contraception in cancer survivors–an expert review Part II. Skin, gastrointestinal, haematological and endocrine cancers 100
Histological evaluation of the prevalence of adenomyosis, myomas and of their concomitance 100
Effect of Estradiol valerate plus dienogest on body composition of healthy women in the menopausal transition: A prospective one-year evaluation 100
Menopausal symptoms in breast cancer survivors on adjuvant endocrine therapy compared with those of menopausal women 100
History of vasomotor symptoms, extent of coronary artery disease, and clinical outcomes after acute coronary syndrome in postmenopausal women 99
Chronic pelvic pain improvement: impact on quality of life and mood 99
Prevalence of menstrual pain in young women: what is dysmenorrhea 99
Fifteen year regional center experience in sperm banking for cancer patients: Use and reproductive outcomes in survivors 99
Folate administration decreases oxidative status and blood pressure in postmenopausal women 98
Impact of transvaginal hydrolaparoscopy ovarian drilling on ovarian stromal blood flow and ovarian volume in clomiphene citrate-resistant PCOS patients: a case-control study 98
Small fetal thymus and adverse obstetrical outcome: a systematic review and a meta-analysis 98
What women think about menopause: An Italian survey 98
Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel 97
Influence of an oral contraceptive containing drospirenone on insulin sensitivity of healthy women 97
Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study 97
Menopause, estrogens, progestins, or their combination on body weight and anthropometric measures 97
Vaginal oxygen plus hyaluronic acid on genito-urinary symptoms of breast cancer survivors 96
Totale 11.774
Categoria #
all - tutte 83.397
article - articoli 82.167
book - libri 0
conference - conferenze 434
curatela - curatele 0
other - altro 461
patent - brevetti 0
selected - selezionate 0
volume - volumi 335
Totale 166.794


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.751 91 38 46 163 33 221 27 429 242 113 104 244
2022/20231.268 213 64 5 83 126 134 14 79 216 12 288 34
2023/2024823 44 120 26 92 68 35 35 92 29 32 66 184
2024/20252.967 67 318 71 92 521 327 316 285 178 207 188 397
2025/20266.169 606 141 329 342 488 627 858 454 505 655 496 668
2026/20271.130 1.130 0 0 0 0 0 0 0 0 0 0 0
Totale 20.755